临床药师干预第二批重点监控药品应用的实践分析  

Practical Analysis of Clinical Pharmacist Intervention in the Application of the Second Batch of Key Monitoring Drugs

作　　者：黄娜 肖慧芳 李明伟 HUANG Na;XIAO Huifang;LI Mingwei(Department of Pharmacy,Henan General Hospital,Zhengzhou 450002,Henan,China)

机构地区：[1]河南省职工医院药学部,河南郑州450002

出　　处：《中国药物滥用防治杂志》2024年第11期2030-2031,2043,共3页Chinese Journal of Drug Abuse Prevention and Treatment

基　　金：河南省医学科技攻关计划项目(编号:LHGJ20210260);河南省医学科技攻关计划项目(编号:LHGJ20230673)。

摘　　要：目的:通过临床药师分析本院“第二批国家重点监控合理用药药品目录”药品使用情况,探索其管控模式及促进临床合理使用重点监控药品。方法:临床药师通过医院信息系统(HIS)对干预前(2022年7月—12月)及干预后(2023年7月—12月)医院在用的27个国家公布的重点监控药品使用数量、不合理用药等数据进行分析。结果:不合理使用第二批重点监控药品的主要原因分布在培训不到位、管理制度不完善、信息系统不健全等方面;干预前后重点监控药品使用情况均呈下降趋势,最大下降幅度达57.89%,合理使用率提升了41.20%,不合格病例下降70.07%。结论:临床药师通过制度修订、用药教育、应用PDCA循环等临床药学实践对第二批重点监控药品的应用进行管理,可降低重点监控药品的使用,有效提高我院重点监控药品的合理使用率。Objective:To analyze the use of drugs in the second batch of the National Key Monitoring and Rational Drug Use Catalogue in our hospital through clinical pharmacists,explore its control mode,and promote the rational use of key monitoring drugs in clinical practice.Methods:Through the hospital information system(HIS),clinical pharmacists analyzed the data of the number of key monitoring drugs and irrational drug use published by 27 countries in the hospital before the intervention(July 2022-December 2022)and after the intervention(July 2023-December 2023).Results:The main reasons for the unreasonable use of the second batch of key monitoring drugs were distributed in the aspects of inadequate training,imperfect management system and imperfect information system.Before and after the intervention,the use of key monitoring drugs showed a downward trend,with the maximum decline of 57.89%,the rational use rate increased by 41.20%,and the unqualified cases decreased by 70.07%.Conclusion:Clinical pharmacists have managed the application of the second batch of key monitored drugs through clinical pharmacy practices such as system revision,medication education,and the application of PDCA cycle,significantly reducing the use of key monitored drugs and effectively improving the rational use rate of key monitored drugs in our hospital.

关 键 词：重点监控药品 药学实践 合理用药 

分 类 号：R95[医药卫生—药学]